WO2001046460A2 - Verfahren zur analyse von nukleinsäuresequenzen - Google Patents
Verfahren zur analyse von nukleinsäuresequenzen Download PDFInfo
- Publication number
- WO2001046460A2 WO2001046460A2 PCT/DE2000/004585 DE0004585W WO0146460A2 WO 2001046460 A2 WO2001046460 A2 WO 2001046460A2 DE 0004585 W DE0004585 W DE 0004585W WO 0146460 A2 WO0146460 A2 WO 0146460A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probes
- dna
- nucleic acid
- analysis
- sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Definitions
- the invention relates to a method for analyzing nucleic acid sequences.
- the field of the invention is the analysis of DNA or RNA and in particular the coupling of a highly parallelizable sample preparation method with an analysis method with high throughput.
- Unknown DNA can be characterized by sequencing it. This is the most precise way to analyze DNA, but sequencing is also very complex. Only very short DNA sections ( ⁇ 1000 nucleobases) can be sequenced at once. If DNA fragments larger than these 1000 nucleobases are to be analyzed on a larger scale, it is necessary to subdivide the DNA, which makes the method more expensive. A more practical method is to look up partial information about an array of different target DNAs.
- Probes can be any nucleic acid sequences of any length.
- Probe sequences can also be put together in a targeted manner in order to find specific target DNA sequences. Oligo fingerprinting is an approach in which this technology is used.
- a library of target DNAs is scanned with short nucleic acid probes. Most of the probes here are only 8-12 bases long.
- One probe at a time is hybridized to a target DNA library immobilized on a nylon membrane. The probe is radioactively labeled and the hybridization is assessed based on the location of the radioactivity. Fluorescently labeled probes have also been used to scan an immobilized DNA array. (Guo, Z., Guilfoyle, RA, Thiel, AJ, Wang, R. and Smith, LM 1994. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotides arrays of glass supports. Nucleic Acids Res. 22: 5456 -5465).
- PNA Peptide Nucleic Acids
- Peptide nucleic acids have an uncharged backbone, which at the same time chemically deviates very strongly from the common sugar-phosphate structure of the backbone in nucleic acids.
- the backbone of a PNA has an amide sequence instead of the sugar-phosphate backbone of ordinary DNA.
- PNA hybridizes very well with DNA complementary sequence.
- the melting temperature of a PNA / DNA hybrid is higher than that of the corresponding DNA / DNA hybrid and the dependence of hybridization on buffer salts is relatively low.
- Matrix-assisted laser desorption / ionization mass spectrometry MALDI is a very powerful development for the analysis of biomolecules (Karas, M. and Hillenkamp, F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10000 daltons. Anal. Chem 60: 2299-2301). An analyte molecule is embedded in a light-absorbing matrix.
- the matrix is vaporized by a short laser pulse and the analyte molecule is thus sent unfragmented into the gas phase.
- the ionization of the analyte is achieved by collisions with matrix molecules.
- An applied voltage accelerates the ions into a field-free flight tube. Due to their different masses, ions are accelerated to different extents. Smaller ions reach the detector earlier than larger ones.
- MALDI is ideal for the analysis of peptides and proteins.
- the analysis of nucleic acids is somewhat more difficult (Gut, IG and Beck, p. 1995. DNA and Matrix Assisted Laser Desorption Ionization Mass Spectrometry. Molecular Bioogy: Current Innovations and Future Trends. 1: 147-157.)
- the sensitivity is approximately 100 times worse than for peptides and decreases disproportionately with increasing fragment size.
- nucleic acids that have a backbone that is often negatively charged the ionization process through the matrix is much more inefficient.
- the choice of the matrix plays an eminently important role.
- Peptides are synthesized by binding the first N-protected amino acid (e.g. Boc) to the support, subsequent deprotection and reaction of the second amino acid with the released NH2 ⁇ group of the first. In a further “capping" step, unreacted ammo functions are withdrawn from a further reaction in the next synthesis cycle. The protective group on the amino function of the second amino acid is removed and the next building block can be coupled. A mixture of amino acids in one or more steps is used to synthesize peptide libraries. PNA and PNA libraries are synthesized analogously. Nuclear acid libraries are mostly obtained by solid phase synthesis with mixtures of different phosphoramidite nucleosides. This can be carried out on commercially available DNA synthesizers without changes in the synthesis protocols.
- N-protected amino acid e.g. Boc
- An essential part of immobilization on a surface is its condition. Systems described so far are mainly made of silicon or metal (magnetic beads). Another method of binding a target DNA is based on a short recognition quenz (eg 20 bases) of the target DNA to hybridize to em surface immobilized oligonucleotide. Enzymatic variants for introducing chemically activated positions into a target DNA have also been described. Here a 5 'is enzymatically carried out.
- Fluorescent-labeled probes have been used in many cases for scanning an immobilized DNA array.
- the simple attachment of Cy3 and Cy5 dyes to the 5 'OH of the respective probe is particularly suitable for fluorescence labeling.
- the fluorescence of the hybridized probes is detected, for example, by means of a confocal microscope.
- the dyes Cy3 and Cy5, among many others, are commercially available.
- the state of the art in terms of sensitivity is defined by a method which includes the DNA to be examined in an agarose matrix, thereby preventing the diffusion and renaturation of the DNA (bisulphite only reacts to single-stranded DNA) and all the steps of precipitation and purification replaced by rapid dialysis (Olek, A. et al., Nucl. Acids. Res. 1996, 24, 5064-5066).
- This method individual cells can be examined, which illustrates the potential of the method.
- only individual regions up to around 3000 base pairs long have been investigated so far; global examination of cells for thousands of possible methylation events is not possible.
- this method too, cannot reliably analyze very small fragments from small sample quantities. Despite the diffusion protection, these are lost through the matrix.
- Coded particles have been used in very different areas for some time. Color-coded beads have been used for the parallel diagnosis of T and B cells (Baran and Parker, Am. J. Clm. Pathol. 1985, 83, 182-9). Beads with radioactive indium have been used as indicators of the motility of the gastrointestinal tract (Dormehl et al Eur. J. Nucl. Med. 1985, 10, 283-5). Two companies have recently been founded that want to run highly parallel diagnostics with color-coded plastic spheres (Lum ex www.lummexcorp.com and Illumina www.illumma.com). These companies use 100 different color-coded beads, to which many different probes can be attached.
- the object of the present invention is to provide an analysis method which is characterized by the coupling of a highly parallelizable sample preparation method with an analysis method with high throughput.
- the object is achieved in that a method for the analysis of nuclear acid sequences is created, whereby the following steps are carried out: a) hybridization of nuclear acid fragments to complementary sequences which are immobilized on coded carriers; b) hybridization of probes to the nucleic acid fragments hybridized in step a); c) sequential identification of the coded carriers and analysis of the probes bound to them in a mass spectrometer; d) assignment of the mass information obtained to the sequences of the probes used; e) comparison of the information thus obtained with a database.
- the nucleic acid fragments hybridized in step a) are DNA or that the nucleic acid fragments hybridized in step a) are RNA or that the nucleic acid fragments hybridized in step a) are obtainable by the polymerase chain reaction or that those in step a ) hybridized nucleic acid fragments are obtainable by restriction digestion or that the hybridized nucleic acid fragments in step a) by treatment with egg A reverse transcriptase and subsequent polymerase chain reaction are available.
- the probes used in step b) are themselves nucleic acids.
- the probes used in step b) are PNA, alkylphosphonate DNA, phosphorothioate DNA or alkylated phosphorothioate DNA.
- the probes used in step b) either carry a single positive or negative net charge or that the probes used in step b) carry chemical groups which change their molecular mass or that the probes used in step b) contain cleavable groups which can be identified by their mass.
- Step b) used probe sequences can be identified via their probe mass. It is further preferred that the probes used in step b) are obtainable by combinatorial synthesis.
- the carriers used in step a) are coded via fluorescent dyes or that the carriers used in step a) are coded via absorbing dyes or that the carriers used in step a) are coded via chemiluminescence or that the m Step a) used carriers are coded via transponders.
- the carriers used in step a) are encoded via nuclides which are resonance, nuclear magnetic resonance or radioactive decomposition by means of electron resonance. event can be detected, or that are in step a) utilization ⁇ Deten exchanger of chemical labels encoded by mass spectrometry which are detectable.
- sequences which are complementary to the primers from the amplification are bound to the supports.
- steps a) and b) are carried out simultaneously.
- the primers used in the amplification carry fluorescent labels which allow a pre-selection of the carriers before the analysis.
- the carriers are distributed over a surface before carrying out step c) in such a way that only one carrier is positioned at predetermined locations.
- the method according to the invention furthermore preferred that the probes be detached from the carrier before, during or after insertion into the mass spectrometer. It is also preferred that a matrix is added for desorption.
- the analysis is carried out using MALDI mass spectrometry.
- an ion trap be used in the mass spectrometric analysis.
- a particularly preferred variant of the method is that the identification of the carrier and the analysis of the hybridized probes take place in one process step.
- the DNA used in step a) is treated beforehand with sulfite or disulfite or another chemical in such a way that all of the cytosine bases which are not methylated at the 5-position of the base are changed in such a way that the base pairing behavior differs Base is formed, while the cytosines methylated on the 5-position remain unchanged.
- Another object of the present invention is a kit containing encoded carriers with bound DNA sequences and / or probes as well as information about the probe sequences and their masses.
- a method for the analysis of nuclear acid sequences is thus described, which is characterized by the following steps: In the first step, any nucleic acid fragments are hybridized to complementary sequences which are immobilized on coded carriers.
- the nucleic acid fragments can be DNA and / or RNA.
- the hybridized DNA fragments are previously produced by the polymerase chain reaction.
- the polymerase chain reaction is preceded by treatment of RNA with a reverse transcriptase.
- the hybridized nucleic acid fragments are produced by restriction digestion.
- the carrier is preferably encoded via fluorescent dyes and / or via absorbing dyes and / or via chemiluminescence and / or via transponders and / or via electron spin resonance and / or via nuclear spin resonance and / or radioactive decay.
- the carriers are encoded using chemical markings which can be detected by mass spectrometry.
- a specific target sequence or several different, defined target sequences can be specifically linked to each carrier.
- sequences which are complementary to the primers from the amplification are bound to the supports.
- the DNA used is preferably treated beforehand with sulfite or disulfite or another chemical in this way. telt that all cytosine bases not methylated at the 5-position of the base are changed in such a way that a base which is different in terms of the base pairing behavior is formed, while the cytosines methylated at the 5-position remain unchanged.
- This embodiment can be used to identify cytosm methylation patterns in DNA samples.
- probes are hybridized to the nucleic acid fragments hybridized in the first step.
- the probes used are themselves DNA.
- the probes are PNA (peptide nucleic acids) and / or alkylphosphonate oligonucleotides and / or phosphorothioate DNA or alkylated phosphorothioate DNA or chimera of these classes of compounds.
- the probes used carry either a positive or negative individual net charge. In a further preferred variant, the probes carry chemical ones
- the probes used contain cleavable groups, the mass of which in turn can be used for their identification.
- the composition of a probe library is selected so that each of the probe sequences used can be clearly identified via the probe mass.
- the probe libraries are produced by combinatorial synthesis.
- the first and second steps of the method are carried out simultaneously.
- the second method step is carried out before the first.
- a sequential identification of the coded carriers and analysis of the probes bound to them is carried out in a mass spectrometer and in a further step the mass information obtained is assigned to the sequences of the probes used.
- the coding mentioned above is used to identify the beads. The coding can be read before, during or after the detection of the hybridized probes.
- the primers used in the amplification carry fluorescent markings which allow the carriers to be pre-selected before the analysis.
- the carriers are lined up prior to the analysis and fed to an analysis one after the other.
- the carriers can be distributed over an upper compartment before the analysis in such a way that only one carrier is positioned at predetermined locations.
- the probes are detached from the respective carrier before, during or after insertion into the mass spectrometer.
- the analysis is carried out using MALDI mass spectrometry.
- a matrix is preferably added for better desorption in the mass spectrometer.
- you can the analysis can be carried out using ESI mass spectrometry.
- the use of an ion trap in mass spectrometric analysis is also preferred.
- the identification of the carrier and the analysis of the hybridized probes takes place in one method step.
- the information is compared with a database.
- the analysis results are previously associated with the coding of the beads. It is thus known which probe patterns correlate with which starting sequence on the beads.
- Another object of the invention is a kit that contains coded carriers with bound DNA sequences and / or probes and / or information about the probe sequences contained and their masses.
- the encoded particles are carboxylate coated.
- Carboxylate groups are esterified with acylisourea (l-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride) for activation.
- the sulfo-NHS ester is then formed.
- An amino-modified oligonucleotide is bound to this.
- the ammo-modified oligonucleotide can also be bound directly to the encoded particles activated with l-ethyl-3- (3-dimethylammopropyl) carbodiimide hydrochloride.
- the beads are activated as described above and subsequently a photolabile linker, as is also known from peptide synthesis, is coupled.
- the oligomer which is to bind the sample DNA and the molecules used for coding, in this case Tn peptides with a characteristic mass, are subsequently coupled to the linkers.
- Known peptide chemistry is used, as is also used in PNA synthesis (HATU as activator, alternatively EDC).
- the PCR product is preferably produced asymmetrically in a manner known per se, in which the forward or reverse primer is used at a concentration approximately 6 times higher. After the 1st hybridization, first with buffer and then very briefly with distilled water. rewashed.
- a buffer suitable for this purpose for example NH 4 C1 0.23 M, citrate 0.023 M, Larouyl sarcosmat 3 , 6%.
- the mass-coded beads with the hybridized probes are distributed in a microtiter plate, preferably one bead per well.
- the microtiter plate is subsequently filled with a water buffer, in the simplest case distilled water is used.
- the microtiter plate is exposed in such a way that the photolabile linker cleaves, in accordance with the specifications of the linker manufacturer, for example with a high pressure mercury lamp.
- the solution is either measured directly in an ESI mass spectrometer or, after mixing with a matrix (see below), dried on a MALDI sample holder and subsequently measured.
- the mass-coded beads with the hybridized probes are applied together with a matrix directly to a MALDI sample carrier.
- the positions of the beads on the sample carrier are identified and the hybridized probes and the mass coding are identified in one step.
- the photolabile linkers are split by the irradiated laser light and the mass coding is also released.
- the beads with the probes hybridized to these are distributed onto the wells of a microtiter plate, as well customary for combinatorial solid-phase syntheses, with each well preferably containing only one bead.
- the wells are filled with a buffer to hold the probes, in the simplest case distilled water can be used. If PNAs are used as probes, the use of 0.1% TFA has been retained.
- the hybridized probes are either thermally or by means of a denaturing reagent, e.g. 40% formamide, detached from the beads.
- a denaturing reagent e.g. 40% formamide
- the solutions are applied directly to the sample holder of the mass spectrometer.
- a Bruker Biflex mass spectrometer with Scout 384 ion source is used. This makes it possible to transfer the solutions from a 384 microtiter plate directly using pins, since the spacing of the wells in the microtiter plate corresponds to the spacing of the samples on the sample carrier.
- the MALDI matrix is applied in the same way below, whereby different variants can be used depending on the probe.
- the masses of the probes are determined as is known to the person skilled in the art and the sequences are used to draw conclusions about the DNA fragments bound to the beads.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/168,310 US20040023217A1 (en) | 1999-12-20 | 2000-12-19 | Method for the analysis of nucleic acid sequences |
AU30015/01A AU3001501A (en) | 1999-12-20 | 2000-12-19 | Method for analyzing nucleic acid sequences |
EP00990568A EP1242628B1 (de) | 1999-12-20 | 2000-12-19 | Verfahren zur analyse von nukleinsäuresequenzen |
DE10084036T DE10084036D2 (de) | 1999-12-20 | 2000-12-19 | Verfahren zur Analyse von Nukleinsäuresequenzen |
CA002397844A CA2397844A1 (en) | 1999-12-20 | 2000-12-19 | Method for analyzing nucleic acid sequences |
DE50013477T DE50013477D1 (de) | 1999-12-20 | 2000-12-19 | Verfahren zur analyse von nukleinsäuresequenzen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19963536.6 | 1999-12-20 | ||
DE19963536A DE19963536C2 (de) | 1999-12-20 | 1999-12-20 | Verfahren zur Analyse von Nukleinsäuresequenzen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001046460A2 true WO2001046460A2 (de) | 2001-06-28 |
WO2001046460A3 WO2001046460A3 (de) | 2002-02-14 |
Family
ID=7934843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2000/004585 WO2001046460A2 (de) | 1999-12-20 | 2000-12-19 | Verfahren zur analyse von nukleinsäuresequenzen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040023217A1 (de) |
EP (1) | EP1242628B1 (de) |
AT (1) | ATE339519T1 (de) |
AU (1) | AU3001501A (de) |
CA (1) | CA2397844A1 (de) |
DE (3) | DE19963536C2 (de) |
WO (1) | WO2001046460A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004018500A1 (en) * | 2002-08-23 | 2004-03-04 | Genera Biosystems Pty Ltd | Coded nucleic acid carriers |
EP1451588A2 (de) * | 2001-11-06 | 2004-09-01 | Agilix Corporation | Empfindliche codierte nachweissysteme |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3566052A4 (de) * | 2017-01-05 | 2020-08-19 | Virgin Instruments Corporation | Ligandenbindungstests unter verwendung von maldi-tof-massenspektrometrie |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032504A2 (en) * | 1995-04-11 | 1996-10-17 | Trustees Of Boston University | Solid phase sequencing of biopolymers |
WO1997037041A2 (en) * | 1996-03-18 | 1997-10-09 | Sequenom, Inc. | Dna sequencing by mass spectrometry |
WO1998031830A1 (en) * | 1997-01-15 | 1998-07-23 | Brax Group Limited | Mass label linked hybridisation probes |
WO1999029897A1 (de) * | 1997-12-05 | 1999-06-17 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren zur identifikation von nucleinsäuren durch elektrospray massenspektrometrie |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5690894A (en) * | 1995-05-23 | 1997-11-25 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US6001571A (en) * | 1995-11-30 | 1999-12-14 | Mandecki; Wlodek | Multiplex assay for nucleic acids employing transponders |
DE19754482A1 (de) * | 1997-11-27 | 1999-07-01 | Epigenomics Gmbh | Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke |
WO1999055886A1 (en) * | 1998-04-24 | 1999-11-04 | Genova Pharmaceuticals Corporation | Function-based gene discovery |
-
1999
- 1999-12-20 DE DE19963536A patent/DE19963536C2/de not_active Expired - Fee Related
-
2000
- 2000-12-19 AT AT00990568T patent/ATE339519T1/de not_active IP Right Cessation
- 2000-12-19 EP EP00990568A patent/EP1242628B1/de not_active Expired - Lifetime
- 2000-12-19 DE DE50013477T patent/DE50013477D1/de not_active Expired - Fee Related
- 2000-12-19 US US10/168,310 patent/US20040023217A1/en not_active Abandoned
- 2000-12-19 DE DE10084036T patent/DE10084036D2/de not_active Expired - Lifetime
- 2000-12-19 AU AU30015/01A patent/AU3001501A/en not_active Abandoned
- 2000-12-19 CA CA002397844A patent/CA2397844A1/en not_active Abandoned
- 2000-12-19 WO PCT/DE2000/004585 patent/WO2001046460A2/de active Search and Examination
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032504A2 (en) * | 1995-04-11 | 1996-10-17 | Trustees Of Boston University | Solid phase sequencing of biopolymers |
WO1997037041A2 (en) * | 1996-03-18 | 1997-10-09 | Sequenom, Inc. | Dna sequencing by mass spectrometry |
WO1998031830A1 (en) * | 1997-01-15 | 1998-07-23 | Brax Group Limited | Mass label linked hybridisation probes |
WO1999029897A1 (de) * | 1997-12-05 | 1999-06-17 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren zur identifikation von nucleinsäuren durch elektrospray massenspektrometrie |
Non-Patent Citations (7)
Title |
---|
BERLIN K ET AL: "ANALYSIS OF NEGATIVELY 'CHARGE TAGGED' DNA BY MATRIX-ASSISTED LASERDESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY" PROCEEDINGS OF THE ANNUAL FREQUENCY CONTROL SYMPOSIUM. PHILADELPHIA, MAY 1987, NEW YORK, IEEE, US, Bd. SYMP. 41, 1987, Seiten 1739-1743, XP000971118 * |
CHEN J ET AL: "A MICROSPHERE-BASED ASSAY FOR MULTIPLEXED SINGLE NUCLEOTIDE POLYMORPHISM ANALYSIS USING SINGLE BASE CHAIN EXTENSION" GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, Bd. 10, Nr. 4, April 2000 (2000-04), Seiten 549-557, XP000927257 ISSN: 1088-9051 in der Anmeldung erw{hnt * |
GUT I G ET AL: "DNA AND MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY" MOLECULAR BIOLOGY: CURRENT INNOVATIONS AND FUTURE TRENDS, HORIZON SCIENTIFIC PRESS, WYMONDHAM, GB, 1995, Seiten 147-157, XP000573516 in der Anmeldung erw{hnt * |
JIANG-BAUCOM P AND GIRARD J E: "DNA typing of human leukocyte antigen sequence polymorphisms by peptide nucleic acid probes and MALDI-TOF mass spectrometry" ANALYTICAL CHEMISTRY, Bd. 69, 1997, Seiten 4894-4898, XP002174822 * |
OLEJNIK J ET AL.: "Photorelease and MALDI analysis of oligonicleotides bound to solid surfaces through photocleavable biotin" BIOPHYSICAL JOURNAL, Bd. 74, Nr. 2Pt2, Februar 1998 (1998-02), Seite A296 XP001015375 * |
OLEK A ET AL: "A modified an improved method for bisulphite based cytosine methylation analysis" NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, Bd. 24, Nr. 24, 1996, Seiten 5064-5066, XP002106408 ISSN: 0305-1048 * |
ROSS ET AL: "DISCRIMINATION OF SINGLE-NUCLEOTIDE POLYMORPHISMS IN HUMAN DNA USING PEPTIDE NUCLEIC ACID PROBES DETECTED BY MALDI-TOF MASS SPECTROMETRY" ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, Bd. 69, Nr. 20, 15. Oktober 1997 (1997-10-15), Seiten 4197-4202, XP002113518 ISSN: 0003-2700 in der Anmeldung erw{hnt * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1451588A2 (de) * | 2001-11-06 | 2004-09-01 | Agilix Corporation | Empfindliche codierte nachweissysteme |
EP1451588A4 (de) * | 2001-11-06 | 2005-03-09 | Agilix Corp | Empfindliche codierte nachweissysteme |
AU2002365271B2 (en) * | 2001-11-06 | 2008-12-11 | Agilix Corporation | Sensitive coded detection systems |
WO2004018500A1 (en) * | 2002-08-23 | 2004-03-04 | Genera Biosystems Pty Ltd | Coded nucleic acid carriers |
EP1534735A1 (de) * | 2002-08-23 | 2005-06-01 | Genera Biosystems Pty Ltd | CODIERTE TRûGER F R NUKLEINSûUREN |
EP1534735A4 (de) * | 2002-08-23 | 2008-02-06 | Genera Biosystems Pty Ltd | CODIERTE TRûGER F R NUKLEINSûUREN |
Also Published As
Publication number | Publication date |
---|---|
DE19963536C2 (de) | 2003-04-10 |
ATE339519T1 (de) | 2006-10-15 |
DE50013477D1 (de) | 2006-10-26 |
US20040023217A1 (en) | 2004-02-05 |
WO2001046460A3 (de) | 2002-02-14 |
DE10084036D2 (de) | 2002-12-12 |
CA2397844A1 (en) | 2001-06-28 |
EP1242628A2 (de) | 2002-09-25 |
EP1242628B1 (de) | 2006-09-13 |
DE19963536A1 (de) | 2001-09-06 |
AU3001501A (en) | 2001-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1232287B1 (de) | Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche | |
EP1036202B1 (de) | Verfahren zur identifikation von nucleinsäuren durch matrix-assistierte laser desorptions/ionisations massenspektrometrie | |
EP1147228B1 (de) | Verfahren zur identifikation von cytosin-methylierungsmustern in genomischen dna-proben | |
DE69626196T2 (de) | Dna-diagnostik mittels massenspektrometrie | |
DE10010280B4 (de) | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben | |
EP1261740A1 (de) | Ligase/polymerase-verfahren zur detektion von cytosin-methylierung in dna proben | |
DE69410291T2 (de) | Schutz von nukleinsäuren und verfahren zur analyse | |
DE10010282B4 (de) | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben | |
EP1038034B1 (de) | Verfahren zur identifikation von nucleinsäuren durch elektrospray massenspektrometrie | |
EP1204763B1 (de) | Verfahren zur charakterisierung von nukleinsäurefragmenten | |
EP1242628B1 (de) | Verfahren zur analyse von nukleinsäuresequenzen | |
DE10240746A1 (de) | Verfahren zum Nachweis von Nukleinsäuresequenzen mittels spaltbarer Sondenmoleküle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WD | Withdrawal of designations after international publication |
Free format text: DE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000990568 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2397844 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 30015/01 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000990568 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10168310 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000990568 Country of ref document: EP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
WD | Withdrawal of designations after international publication |
Designated state(s): DE |